Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
Fri, 14th Oct 2016 12:54
(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.
Read more
Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.
Read more
| Thursday 25 January | |
| Britvic PLC | Trading Statement |
| Conduit Holdings Ltd | Trading Statement |
| CVS Group PLC | Trading Statement |
| Dr Martens PLC | Trading Statement |
| Fevertree Drinks PLC | Trading Statement |
| Foxtons Group PLC | Full Year Results |
| Fuller, Smith & Turner PLC | Trading Statement |
| Halfords Group PLC | Trading Statement |
| Idox PLC | Full Year Results |
| IG Group Holdings PLC | Half Year Results |
| Intermediate Capital Group PLC | Trading Statement |
| Mitie Group PLC | Trading Statement |
| NCC Group PLC | Half Year Results |
| Newmark Security PLC | Half Year Results |
| Next 15 Group PLC | Trading Statement |
| PPHE Hotel Group Ltd | Trading Statement |
| Secure Trust Bank PLC | Trading Statement |
| St James's Place PLC | Trading Statement |
| Time Finance PLC | Half Year Results |
| Titon Holdings PLC | Full Year Results |
| Wizz Air Holdings PLC | Q3 Results |
| Workspace Group PLC | Trading Statement |
| Friday 26 January | |
| Paragon Banking Group PLC | Trading Statement |
| Record PLC | Trading Statement |
| Superdry PLC | Half Year Results |
| Taylor Maritime Investments Ltd | Trading Statement |
| WH Smith PLC | Trading Statement |
| YouGov PLC | Trading Statement |
| Monday 29 January | |
| Team Internet Group PLC | Trading Statement |
| Tuesday 30 January | |
| Diaceutics PLC | Trading Statement |
| Diageo PLC | Half Year Results |
| Kromek Group PLC | Half Year Results |
| Luceco PLC | Trading Statement |
| Oxford Cannabinoid Technologies Holdings PLC | Half Year Results |
| Pets at Home Group PLC | Trading Statement |
| Renewi PLC | Trading Statement |
| Saga PLC | Trading Statement |
| SSP Group PLC | Trading Statement |
| SThree PLC | Full Year Results |
| Synthomer PLC | Trading Statement |
| Wednesday 31 January | |
| Aberforth Smaller Companies Trust PLC | Full Year Results |
| abrdn Private Equity Opportunities Trust PLC | Full Year Results |
| Ecora Resources PLC | Trading Statement |
| GSK PLC | Full Year Results |
| ITM Power PLC | Half Year Results |
| NWF Group PLC | Half Year Results |
| Comments and questions to newsroom@alliancenews.com | |
| A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional. | |
| Copyright 2024 Alliance News Ltd. All Rights Reserved. | |
Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.
Read moreJan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.
Read moreOxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.
Read more(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.
Read more(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.
Read more(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.
Read moreJan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.
Read more(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:
Read more(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.
Read more(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.
Read more(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.
Read more
Last checked at